Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
10% owner at MBX Biosciences; 10% owner at Avalyn Pharma; 10% owner at Upstream Bio.
- Rank
- 567th of 809
- Companies held
- 3
- Largest holding
- MBX, 71.3% of total
- Latest SEC filing
- May 1, 2026
What the $134M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| MBX Biosciences MBX Common Stock | Directly | 1,790,122 | $53.41 | $95.6M | 71.3% | Form 4, Sep 16, 2024 |
| Avalyn Pharma AVLN Common Stock | Directly | 1,275,486 | $28.70 | $36.6M | 27.3% | Form 4, May 1, 2026 |
| Upstream Bio UPB Common Stock | Directly | 894,733 | $2.00 | $1.8M | 1.3% | Form 4, Oct 15, 2024 |
Share counts are the amounts Wellington Biomedical Innovation Master Investors (Cayman) II L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 564 | Sequoia Capital Global Growth Fund III - U.S./India Annex Fund, L.P. 10% owner, DoorDash | $136M |
| 565 | KLP 2006-N3 Family Trust Insider, Hyatt Hotels | $135M |
| 566 | Charles F. Dolan 2009 Family Trust Fbo Marianne Dolan Weber Insider, MSG Knickerbockers | $135M |
| 567 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner, MBX Biosciences | $134M |
| 568 | Accel London Investors 2016 L.P. 10% owner, UiPath | $132M |
| 569 | CilMar Ventures, LLC Series A 10% owner, Falcon's Beyond Global | $132M |
| 570 | Idea Men, LLC Director, GoodRx Holdings | $130M |
Other MBX Biosciences insiders
All MBX insiders- P. Kent Hawryluk$64.9MPresident & CEO. #2115 overall
- James M. Cornelius$5.5MDirector. #13634 overall
- Steven L. Hoerter$5.2MChairman, President and CEO. #14008 overall
- John W. Smither$1.5MChief Financial Officer. #12738 overall
Questions
How much stock does Wellington Biomedical Innovation Master Investors (Cayman) II L.P. own?
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. holds $134,006,330 in listed stock based on SEC filings and current prices, mostly MBX Biosciences (MBX). That ranks 567th on the Stock Rich List.
Is this Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.